港股異動 | 中國食品(0506.HK)直線拉昇漲超4% 2020年純利同比增長19.4%
格隆匯3月23日丨中國食品(0506.HK)午後直線拉昇,現報3.23港元,漲4.53%,最新總市值90億港元。中國食品今日午間公佈2020年度業績稱,期內實現收入172.49億元(人民幣,下同),同比增長0.4%;毛利68.26億元,同比增長8.8%,毛利率由上年同期的36.5%升至39.6%;公司擁有人應占溢利4.99億元,同比增長19.4%;每股基本盈利17.83分,宣派末期股息每股0.089元。公司業務4月份已開始恢復增長,第二季度業績大幅度改善,大致追回疫情期間收入利潤損失。下半年部份地區疫情雖出現反覆,但公司下半年銷量及收入同比皆錄得增長。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.